Brian Friedrich

Associate Director - Analytical Development Genentech

Brian Friedrich, Ph.D., is currently the Associate Director of Analytical Development at Genentech (Roche), where he establishes analytical capabilities for raw materials, CAR-T products, and gene therapy products. Previously, he served as the Head of Bioassay for mRNA Analytical Development at Sanofi, leading CMC activities for mRNA-based vaccines. With extensive experience at Merck and Nanoviricides, Dr. Friedrich specializes in developing robust control strategies, characterizing mRNA/LNP complexes, and navigating regulatory submissions for novel modalities.

Seminars

Tuesday 21st July 2026
Revolutionizing Analytical Techniques to Improve the Determination of mRNA-LNP Integrity, Control Strategy & Efficiency of the Final Product
Tuesday 21st July 2026
Correlating Structure with Function: Establishing Physicochemical Surrogates for mRNA & Plasmid Potency
4:15 pm
  • Elucidating the structure-function relationship of mRNA and plasmid DNA
  • Physicochemical analysis as a proxy for potency
  • Evolving the control strategy
Brian Friedrich - 6th mRNA-Based Therapeutics Summit Speaker